As of Nov 13, 2026. At least 3 observations, ranked by Alpha IQ over 5 trading days. 1,967 eligible records before the optional luck filter.
Five trading days measures a short-term reaction. A complete corrected luck check for the first 100 is unavailable.
Link an account to see your stake.
#1 Daron Evans
12 buys · 0 sales · 5 trading days
Alpha IQ82.8
Why this rank?
9 of 12 worked
Luck not ruled out
Luck could explain this record.
This rank comes from 12 purchases and 0 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
12 trade dates · 10 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought RZLTMay 23, 2024$165
Stock +26.0%; recorded comparison +10.5%; outcome in the trade's direction +15.5%.
1 reported line and filing sources
May 23, 2024 · $165 · Form 4Stock +26.0% versus the recorded factor comparison +10.5%.
Bought RZLTMar 26, 2025$57,700
Stock -13.7%; recorded comparison -0.2%; outcome in the trade's direction -13.4%.
2 reported lines and filing sources
Mar 26, 2025 · $28,800 · Form 4Stock -13.7% versus the recorded factor comparison -0.2%.
Mar 26, 2025 · $28,900 · Form 4Stock -13.7% versus the recorded factor comparison -0.2%.
Bought RZLTJun 24, 2025$20,250
Stock +4.2%; recorded comparison +7.7%; outcome in the trade's direction -3.5%.
1 reported line and filing sources
Jun 24, 2025 · $20,250 · Form 4Stock +4.2% versus the recorded factor comparison +7.7%.
Bought RZLTJun 14, 2024$161,568
Stock +7.8%; recorded comparison -6.9%; outcome in the trade's direction +14.7%.
1 reported line and filing sources
Jun 14, 2024 · $161,568 · Form 4Stock +7.8% versus the recorded factor comparison -6.9%.
Bought RZLTMay 29, 2024$1,579
Stock +41.9%; recorded comparison +11.7%; outcome in the trade's direction +30.2%.
1 reported line and filing sources
May 29, 2024 · $1,579 · Form 4Stock +41.9% versus the recorded factor comparison +11.7%.
Bought RZLTMar 8, 2024$96,345
Stock -6.3%; recorded comparison -2.5%; outcome in the trade's direction -3.8%.
1 reported line and filing sources
Mar 8, 2024 · $96,345 · Form 4Stock -6.3% versus the recorded factor comparison -2.5%.
Bought RZLTFeb 16, 2024$54,411
Stock +16.6%; recorded comparison +11.4%; outcome in the trade's direction +5.2%.
1 reported line and filing sources
Feb 16, 2024 · $54,411 · Form 4Stock +16.6% versus the recorded factor comparison +11.4%.
Bought RZLTDec 18, 2024$42,900
Stock +22.8%; recorded comparison +10.5%; outcome in the trade's direction +12.3%.
1 reported line and filing sources
Dec 18, 2024 · $42,900 · Form 4Stock +22.8% versus the recorded factor comparison +10.5%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001411726. Profile company CIK 0001509261. Rezolute, Inc.
Recorded role: CFO · RZLT.
12 obs. Confidence 78; 5-day hit rate 75.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 9 of 12 represented trade dates; upper tail 4.377e-2; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 10 windows, with 7 wins and upper tail 1.186e-1.
This rank comes from 14 purchases and 2 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
24 trade dates · 11 nonoverlapping windows · 3 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought SYRSDec 21, 2023$3,999,998
Stock +0.9%; recorded comparison -1.4%; outcome in the trade's direction +2.3%.
1 reported line and filing sources
Dec 21, 2023 · $3,999,998 · Form 4Stock +0.9% versus SPY -1.4%.
Sold SRRKOct 7, 2024$14,025,000
Stock -16.8%; recorded comparison +14.4%; outcome in the trade's direction +31.2%.
1 reported line and filing sources
Oct 7, 2024 · $14,025,000 · Form 4Stock -16.8% versus the recorded factor comparison +14.4%.
Bought ALMSMay 2, 2025$727,636
Stock +2.5%; recorded comparison -0.3%; outcome in the trade's direction +2.8%.
1 reported line and filing sources
May 2, 2025 · $727,636 · Form 4Stock +2.5% versus the recorded factor comparison -0.3%.
Bought ALMSNov 20, 2025$905,350
Stock +1.5%; recorded comparison +3.2%; outcome in the trade's direction -1.7%.
1 reported line and filing sources
Nov 20, 2025 · $905,350 · Form 4Stock +1.5% versus the recorded factor comparison +3.2%.
Bought SRRKOct 3, 2025$18,807,352
Stock -19.2%; recorded comparison +3.3%; outcome in the trade's direction -22.5%.
6 reported lines and filing sources
Oct 3, 2025 · $2,083,268 · Form 4Stock -19.2% versus the recorded factor comparison +3.3%.
Oct 6, 2025 · $697,706 · Form 4Stock -19.2% versus the recorded factor comparison +3.3%.
Oct 3, 2025 · $392,102 · Form 4Stock -19.2% versus the recorded factor comparison +3.3%.
Oct 6, 2025 · $543,321 · Form 4Stock -19.2% versus the recorded factor comparison +3.3%.
Oct 6, 2025 · $3,127,781 · Form 4Stock -19.2% versus the recorded factor comparison +3.3%.
Oct 3, 2025 · $11,963,174 · Form 4Stock -19.2% versus the recorded factor comparison +3.3%.
Bought ALMSJul 1, 2024$25,000,000
Stock -5.5%; recorded comparison -0.2%; outcome in the trade's direction -5.2%.
1 reported line and filing sources
Jul 1, 2024 · $25,000,000 · Form 4Stock -5.5% versus the recorded factor comparison -0.2%.
Bought ALMSNov 17, 2025$1,529,865
Stock +16.3%; recorded comparison +12.2%; outcome in the trade's direction +4.1%.
3 reported lines and filing sources
Nov 18, 2025 · $621,045 · Form 4Stock +16.3% versus the recorded factor comparison +12.2%.
Nov 19, 2025 · $903,784 · Form 4Stock +16.3% versus the recorded factor comparison +12.2%.
Nov 17, 2025 · $5,036 · Form 4Stock +16.3% versus the recorded factor comparison +12.2%.
Bought ALMSNov 13, 2025$1,449,940
Stock +30.9%; recorded comparison +15.8%; outcome in the trade's direction +15.1%.
1 reported line and filing sources
Nov 13, 2025 · $1,449,940 · Form 4Stock +30.9% versus the recorded factor comparison +15.8%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001253170. Profile company CIK 0001933414. Mineralys Therapeutics, Inc.
Recorded role: Director · MLYS.
16 obs. Confidence 86; 5-day hit rate 68.8%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 16.6):
Past calls: 65% directionally correct over 3 months (adjusted toward 50% peer prior; 87% observed; recency-weighted sample 16.6)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 11 of 16 represented trade dates; upper tail 6.496e-2; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 11 windows, with 7 wins and upper tail 2.044e-1.
This rank comes from 17 purchases and 0 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
20 trade dates · 9 nonoverlapping windows · 2 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought PLSEDec 11, 2023$843,504
Stock +14.0%; recorded comparison -4.0%; outcome in the trade's direction +17.9%.
1 reported line and filing sources
Dec 11, 2023 · $843,504 · Form 4Stock +14.0% versus the recorded factor comparison -4.0%.
Bought PLSEDec 7, 2023$687,890
Stock +6.2%; recorded comparison -4.0%; outcome in the trade's direction +10.2%.
1 reported line and filing sources
Dec 7, 2023 · $687,890 · Form 4Stock +6.2% versus the recorded factor comparison -4.0%.
Bought PLSENov 30, 2023$1,385,673
Stock -10.6%; recorded comparison -10.2%; outcome in the trade's direction -0.5%.
1 reported line and filing sources
Nov 30, 2023 · $1,385,673 · Form 4Stock -10.6% versus the recorded factor comparison -10.2%.
Bought PLSEDec 5, 2023$616,636
Stock +1.4%; recorded comparison -3.3%; outcome in the trade's direction +4.7%.
1 reported line and filing sources
Dec 5, 2023 · $616,636 · Form 4Stock +1.4% versus the recorded factor comparison -3.3%.
Bought PLSEDec 12, 2023$164,691
Stock +27.7%; recorded comparison +2.2%; outcome in the trade's direction +25.5%.
1 reported line and filing sources
Dec 12, 2023 · $164,691 · Form 4Stock +27.7% versus the recorded factor comparison +2.2%.
Bought PLSEDec 1, 2023$413,592
Stock -0.1%; recorded comparison -9.4%; outcome in the trade's direction +9.3%.
1 reported line and filing sources
Dec 1, 2023 · $413,592 · Form 4Stock -0.1% versus the recorded factor comparison -9.4%.
Bought PLSENov 28, 2023$1,117,085
Stock +3.2%; recorded comparison -4.4%; outcome in the trade's direction +7.6%.
1 reported line and filing sources
Nov 28, 2023 · $1,117,085 · Form 4Stock +3.2% versus the recorded factor comparison -4.4%.
Bought PLSEDec 11, 2024$101,344
Stock +1.9%; recorded comparison +6.3%; outcome in the trade's direction -4.4%.
1 reported line and filing sources
Dec 11, 2024 · $101,344 · Form 4Stock +1.9% versus the recorded factor comparison +6.3%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001055919. Profile company CIK 0001625101. PULSE BIOSCIENCES, INC.
Recorded role: CEO · PLSE.
17 obs. Confidence 88; 5-day hit rate 58.8%. Confidence measures the sample, not a probability of future success.
Luck reference: 10 of 17 represented trade dates; upper tail 2.154e-1; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 9 windows, with 4 wins and upper tail 6.695e-1.
This rank comes from 8 purchases and 0 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
9 trade dates · 7 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought RZLTFeb 16, 2024$9,142
Stock +10.2%; recorded comparison +7.4%; outcome in the trade's direction +2.8%.
1 reported line and filing sources
Feb 16, 2024 · $9,142 · Form 4Stock +10.2% versus the recorded factor comparison +7.4%.
Bought RZLTMay 23, 2024$4,080
Stock +26.0%; recorded comparison +10.5%; outcome in the trade's direction +15.5%.
1 reported line and filing sources
May 23, 2024 · $4,080 · Form 4Stock +26.0% versus the recorded factor comparison +10.5%.
Bought RZLTMar 28, 2024$1,275
Stock +4.5%; recorded comparison -2.8%; outcome in the trade's direction +7.3%.
1 reported line and filing sources
Mar 28, 2024 · $1,275 · Form 4Stock +4.5% versus the recorded factor comparison -2.8%.
Bought RZLTMar 7, 2024$20,650
Stock +0.2%; recorded comparison +0.6%; outcome in the trade's direction -0.3%.
3 reported lines and filing sources
Mar 14, 2024 · $18,800 · Form 4Stock +5.6% versus the recorded factor comparison +3.2%.
Mar 7, 2024 · $925 · Form 4Stock -10.5% versus the recorded factor comparison -4.8%.
Mar 7, 2024 · $925 · Form 4Stock +5.6% versus the recorded factor comparison +3.2%.
Bought RZLTFeb 23, 2024$10,140
Stock +5.3%; recorded comparison -6.2%; outcome in the trade's direction +11.5%.
1 reported line and filing sources
Feb 23, 2024 · $10,140 · Form 4Stock +5.3% versus the recorded factor comparison -6.2%.
Bought RZLTJun 25, 2025$10,939
Stock +11.8%; recorded comparison +10.8%; outcome in the trade's direction +1.0%.
1 reported line and filing sources
Jun 25, 2025 · $10,939 · Form 4Stock +11.8% versus the recorded factor comparison +10.8%.
Bought RZLTJun 14, 2024$15,640
Stock +7.8%; recorded comparison -6.9%; outcome in the trade's direction +14.7%.
1 reported line and filing sources
Jun 14, 2024 · $15,640 · Form 4Stock +7.8% versus the recorded factor comparison -6.9%.
Bought RZLTDec 16, 2025$47,600
Stock +36.3%; recorded comparison +14.1%; outcome in the trade's direction +22.2%.
1 reported line and filing sources
Dec 16, 2025 · $47,600 · Form 4Stock +36.3% versus the recorded factor comparison +14.1%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001829608. Profile company CIK 0001509261. Rezolute, Inc.
Recorded role: Chief Officer · RZLT.
8 obs. Confidence 63; 5-day hit rate 87.5%. Confidence measures the sample, not a probability of future success.
Luck reference: 7 of 8 represented trade dates; upper tail 2.189e-2; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 9.530e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 7 windows, with 6 wins and upper tail 4.188e-2.
This rank comes from 9 purchases and 1 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
10 trade dates · 8 nonoverlapping windows · 2 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought TISIJun 14, 2024$33,152
Stock +4.4%; recorded comparison -0.4%; outcome in the trade's direction +4.8%.
1 reported line and filing sources
Jun 14, 2024 · $33,152 · Form 4Stock +4.4% versus SPY -0.4%.
Bought TISIJun 3, 2024$20,490
Stock +1.8%; recorded comparison +1.3%; outcome in the trade's direction +0.6%.
1 reported line and filing sources
Jun 3, 2024 · $20,490 · Form 4Stock +1.8% versus SPY +1.3%.
Bought TISIMay 21, 2024$42,873
Stock +16.1%; recorded comparison +0.3%; outcome in the trade's direction +15.9%.
1 reported line and filing sources
May 21, 2024 · $42,873 · Form 4Stock +16.1% versus SPY +0.3%.
Bought TISIMar 28, 2024$91,340
Stock +3.5%; recorded comparison -0.7%; outcome in the trade's direction +4.1%.
1 reported line and filing sources
Mar 28, 2024 · $91,340 · Form 4Stock +3.5% versus SPY -0.7%.
Bought TISIMar 22, 2024$32,437
Stock +31.3%; recorded comparison +0.1%; outcome in the trade's direction +31.1%.
1 reported line and filing sources
Mar 22, 2024 · $32,437 · Form 4Stock +31.3% versus SPY +0.1%.
Bought TISIMar 19, 2024$116,110
Stock +15.2%; recorded comparison +0.2%; outcome in the trade's direction +15.0%.
1 reported line and filing sources
Mar 19, 2024 · $116,110 · Form 4Stock +15.2% versus SPY +0.2%.
Bought TISIJun 10, 2025$5,706
Stock -0.3%; recorded comparison -1.6%; outcome in the trade's direction +1.3%.
1 reported line and filing sources
Jun 10, 2025 · $5,706 · Form 4Stock -0.3% versus SPY -1.6%.
Bought TISIJun 5, 2025$36,738
Stock +9.7%; recorded comparison +0.5%; outcome in the trade's direction +9.2%.
1 reported line and filing sources
Jun 5, 2025 · $36,738 · Form 4Stock +9.7% versus SPY +0.5%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001537323. Profile company CIK 0000318833. TEAM INC
Recorded role: 10% Owner · TISI.
10 obs. Confidence 71; 5-day hit rate 80.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 8 of 10 represented trade dates; upper tail 3.497e-2; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 8 windows, with 6 wins and upper tail 1.062e-1.
This rank comes from 10 purchases and 1 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
9 trade dates · 7 nonoverlapping windows · 5 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought ATHADec 27, 2023$73,266
Stock +30.5%; recorded comparison -0.1%; outcome in the trade's direction +30.6%.
1 reported line and filing sources
Dec 27, 2023 · $73,266 · Form 4Stock +30.5% versus SPY -0.1%.
Bought VRCADec 27, 2023$574,027
Stock -13.7%; recorded comparison -2.4%; outcome in the trade's direction -11.3%.
1 reported line and filing sources
Dec 27, 2023 · $574,027 · Form 4Stock -13.7% versus the recorded factor comparison -2.4%.
Bought VRCADec 21, 2023$1,234,000
Stock +4.5%; recorded comparison -1.9%; outcome in the trade's direction +6.4%.
1 reported line and filing sources
Dec 21, 2023 · $1,234,000 · Form 4Stock +4.5% versus the recorded factor comparison -1.9%.
Bought ATXSDec 21, 2023$4,588,000
Stock +14.7%; recorded comparison -0.2%; outcome in the trade's direction +14.9%.
1 reported line and filing sources
Dec 21, 2023 · $4,588,000 · Form 4Stock +14.7% versus SPY -0.2%.
Bought ALDXApr 4, 2024$655,112
Stock -5.0%; recorded comparison -10.8%; outcome in the trade's direction +5.8%.
1 reported line and filing sources
Apr 4, 2024 · $655,112 · Form 4Stock -5.0% versus the recorded factor comparison -10.8%.
Bought ALDXApr 1, 2024$27,216
Stock +2.4%; recorded comparison +3.4%; outcome in the trade's direction -1.0%.
1 reported line and filing sources
Apr 1, 2024 · $27,216 · Form 4Stock +2.4% versus the recorded factor comparison +3.4%.
Bought ATXSFeb 1, 2024$29,999,522
Stock +6.9%; recorded comparison +1.7%; outcome in the trade's direction +5.2%.
1 reported line and filing sources
Feb 1, 2024 · $29,999,522 · Form 4Stock +6.9% versus SPY +1.7%.
Sold ALDXApr 3, 2025$4,828,000
Stock +8.7%; recorded comparison +8.5%; outcome in the trade's direction -0.3%.
1 reported line and filing sources
Apr 3, 2025 · $4,828,000 · Form 4Stock +8.7% versus the recorded factor comparison +8.5%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001224962. Profile company CIK 0001814114. Orchestra BioMed Holdings, Inc.
Recorded role: Director · OBIO.
11 obs. Confidence 75; 5-day hit rate 72.7%. Confidence measures the sample, not a probability of future success.
Luck reference: 7 of 9 represented trade dates; upper tail 6.161e-2; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 7 windows, with 5 wins and upper tail 1.779e-1.
This rank comes from 13 purchases and 0 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
13 trade dates · 6 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought YQAug 21, 2026$2,079
Stock -17.6%; recorded comparison +0.5%; outcome in the trade's direction -18.1%.
1 reported line and filing sources
Aug 21, 2026 · $2,079 · Form 4Stock -17.6% versus SPY +0.5%.
Bought YQJul 2, 2026$41,753
Stock -4.0%; recorded comparison -0.3%; outcome in the trade's direction -3.7%.
1 reported line and filing sources
Jul 2, 2026 · $41,753 · Form 4Stock -4.0% versus SPY -0.3%.
Bought YQJul 21, 2026$20,149
Stock -21.5%; recorded comparison -0.8%; outcome in the trade's direction -20.8%.
1 reported line and filing sources
Jul 21, 2026 · $20,149 · Form 4Stock -21.5% versus SPY -0.8%.
Bought YQJul 30, 2026$931
Stock +24.3%; recorded comparison +3.5%; outcome in the trade's direction +20.7%.
1 reported line and filing sources
Jul 30, 2026 · $931 · Form 4Stock +24.3% versus SPY +3.5%.
Bought YQAug 13, 2026$2,054
Stock +2.4%; recorded comparison -1.7%; outcome in the trade's direction +4.0%.
1 reported line and filing sources
Aug 13, 2026 · $2,054 · Form 4Stock +2.4% versus SPY -1.7%.
Bought YQAug 28, 2026$8,432
Stock +119.7%; recorded comparison +0.1%; outcome in the trade's direction +119.6%.
1 reported line and filing sources
Aug 28, 2026 · $8,432 · Form 4Stock +119.7% versus SPY +0.1%.
Bought YQAug 26, 2026$19,927
Stock +41.4%; recorded comparison +0.1%; outcome in the trade's direction +41.3%.
1 reported line and filing sources
Aug 26, 2026 · $19,927 · Form 4Stock +41.4% versus SPY +0.1%.
Bought YQSep 2, 2026$19,819
Stock +35.7%; recorded comparison -1.1%; outcome in the trade's direction +36.9%.
1 reported line and filing sources
Sep 2, 2026 · $19,819 · Form 4Stock +35.7% versus SPY -1.1%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001843196. Profile company CIK 0001821468. 17 Education & Technology Group Inc.
Recorded role: Chief Executive Officer · YQ.
13 obs. Confidence 80; 5-day hit rate 61.5%. Confidence measures the sample, not a probability of future success.
Luck reference: 8 of 13 represented trade dates; upper tail 2.063e-1; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 6 windows, with 2 wins and upper tail 8.527e-1.
This rank comes from 14 purchases and 0 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
16 trade dates · 7 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought CALCJul 22, 2025$5,663
Stock -12.4%; recorded comparison +0.0%; outcome in the trade's direction -12.4%.
1 reported line and filing sources
Jul 22, 2025 · $5,663 · Form 4Stock -12.4% versus SPY +0.0%.
Bought CALCJul 21, 2025$5,055
Stock 0.0%; recorded comparison +1.0%; outcome in the trade's direction -1.0%.
1 reported line and filing sources
Jul 21, 2025 · $5,055 · Form 4Stock 0.0% versus SPY +1.0%.
Bought CALCJul 18, 2025$5,760
Stock +26.2%; recorded comparison +1.5%; outcome in the trade's direction +24.7%.
1 reported line and filing sources
Jul 18, 2025 · $5,760 · Form 4Stock +26.2% versus SPY +1.5%.
Bought CALCJul 14, 2025$15,810
Stock +92.2%; recorded comparison +1.6%; outcome in the trade's direction +90.6%.
1 reported line and filing sources
Jul 14, 2025 · $15,810 · Form 4Stock +92.2% versus SPY +1.6%.
Bought CALCJul 9, 2025$8,024
Stock +55.6%; recorded comparison +0.4%; outcome in the trade's direction +55.2%.
1 reported line and filing sources
Jul 9, 2025 · $8,024 · Form 4Stock +55.6% versus SPY +0.4%.
Bought CALCAug 21, 2025$9,797
Stock +11.1%; recorded comparison -0.3%; outcome in the trade's direction +11.5%.
1 reported line and filing sources
Aug 21, 2025 · $9,797 · Form 4Stock +11.1% versus SPY -0.3%.
Bought CALCAug 19, 2025$8,230
Stock -2.2%; recorded comparison +2.1%; outcome in the trade's direction -4.3%.
2 reported lines and filing sources
Aug 19, 2025 · $2,790 · Form 4Stock -2.2% versus SPY +2.1%.
Aug 20, 2025 · $5,440 · Form 4Stock -2.2% versus SPY +2.1%.
Bought CALCAug 15, 2025$14,709
Stock +3.2%; recorded comparison +0.8%; outcome in the trade's direction +2.4%.
1 reported line and filing sources
Aug 15, 2025 · $14,709 · Form 4Stock +3.2% versus SPY +0.8%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001576244. Profile company CIK 0001534133. CalciMedica, Inc.
Recorded role: Chief Officer · CALC.
14 obs. Confidence 83; 5-day hit rate 57.1%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 11.5):
Past calls: 56% directionally correct over 3 months (adjusted toward 50% peer prior; 70% observed; recency-weighted sample 11.5)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 8 of 14 represented trade dates; upper tail 2.935e-1; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 7 windows, with 5 wins and upper tail 1.713e-1.
This rank comes from 9 purchases and 0 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
12 trade dates · 6 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought GCTSNov 25, 2025$21,408
Stock +7.6%; recorded comparison +0.3%; outcome in the trade's direction +7.2%.
1 reported line and filing sources
Nov 25, 2025 · $21,408 · Form 4Stock +7.6% versus SPY +0.3%.
Bought GCTSMay 23, 2025$80,080
Stock -3.8%; recorded comparison +0.8%; outcome in the trade's direction -4.6%.
1 reported line and filing sources
May 23, 2025 · $80,080 · Form 4Stock -3.8% versus SPY +0.8%.
Bought GCTSMay 20, 2025$101,480
Stock -0.9%; recorded comparison +1.2%; outcome in the trade's direction -2.2%.
1 reported line and filing sources
May 20, 2025 · $101,480 · Form 4Stock -0.9% versus SPY +1.2%.
Bought GCTSJun 10, 2025$100,200
Stock +13.2%; recorded comparison -1.6%; outcome in the trade's direction +14.7%.
2 reported lines and filing sources
Jun 10, 2025 · $52,200 · Form 4Stock +13.2% versus SPY -1.6%.
Jun 10, 2025 · $48,000 · Form 4Stock +13.2% versus SPY -1.6%.
Bought GCTSJun 4, 2025$163,787
Stock +33.0%; recorded comparison -0.4%; outcome in the trade's direction +33.4%.
3 reported lines and filing sources
Jun 4, 2025 · $81,600 · Form 4Stock +33.0% versus SPY -0.4%.
Jun 5, 2025 · $60,461 · Form 4Stock +33.0% versus SPY -0.4%.
Jun 5, 2025 · $21,726 · Form 4Stock +33.0% versus SPY -0.4%.
Bought GCTSAug 15, 2025$152,460
Stock +8.5%; recorded comparison +0.8%; outcome in the trade's direction +7.6%.
1 reported line and filing sources
Aug 15, 2025 · $152,460 · Form 4Stock +8.5% versus SPY +0.8%.
Bought GCTSSep 12, 2025$66,541
Stock +11.7%; recorded comparison +0.5%; outcome in the trade's direction +11.2%.
1 reported line and filing sources
Sep 12, 2025 · $66,541 · Form 4Stock +11.7% versus SPY +0.5%.
Bought GCTSSep 4, 2025$23,785
Stock +13.5%; recorded comparison +1.9%; outcome in the trade's direction +11.7%.
2 reported lines and filing sources
Sep 5, 2025 · $13,390 · Form 4Stock +13.5% versus SPY +1.9%.
Sep 4, 2025 · $10,395 · Form 4Stock +13.5% versus SPY +1.9%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0002007757. Profile company CIK 0001851961. GCT Semiconductor Holding, Inc.
Recorded role: Director · GCTS.
9 obs. Confidence 68; 5-day hit rate 66.7%. Confidence measures the sample, not a probability of future success.
Luck reference: 6 of 9 represented trade dates; upper tail 1.877e-1; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 1.000e+0. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 6 windows, with 4 wins and upper tail 2.782e-1.
This rank comes from 6 purchases and 1 sales, measured over 5 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
8 trade dates · 6 nonoverlapping windows · 2 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Sold SFMay 13, 2025$1,290,003
Stock -2.3%; recorded comparison -0.4%; outcome in the trade's direction +1.9%.
1 reported line and filing sources
May 13, 2025 · $1,290,003 · Form 4Stock -2.3% versus the recorded factor comparison -0.4%.
Bought ADVMar 4, 2024$54,026
Stock +15.7%; recorded comparison +6.9%; outcome in the trade's direction +8.8%.
1 reported line and filing sources
Mar 4, 2024 · $54,026 · Form 4Stock +15.7% versus the recorded factor comparison +6.9%.
Bought ADVNov 11, 2024$54,869
Stock +3.4%; recorded comparison -5.2%; outcome in the trade's direction +8.6%.
1 reported line and filing sources
Nov 11, 2024 · $54,869 · Form 4Stock +3.4% versus the recorded factor comparison -5.2%.
Bought ADVMay 14, 2025$86,123
Stock +6.4%; recorded comparison -1.2%; outcome in the trade's direction +7.7%.
1 reported line and filing sources
May 14, 2025 · $86,123 · Form 4Stock +6.4% versus SPY -1.2%.
Bought ADVJun 21, 2024$111,584
Stock +9.1%; recorded comparison +7.4%; outcome in the trade's direction +1.7%.
1 reported line and filing sources
Jun 21, 2024 · $111,584 · Form 4Stock +9.1% versus the recorded factor comparison +7.4%.
Bought ADVSep 9, 2024$50,961
Stock +8.0%; recorded comparison +3.9%; outcome in the trade's direction +4.1%.
1 reported line and filing sources
Sep 9, 2024 · $50,961 · Form 4Stock +8.0% versus the recorded factor comparison +3.9%.
Bought ADVMay 18, 2026$55,360
Stock +8.9%; recorded comparison +1.8%; outcome in the trade's direction +7.1%.
2 reported lines and filing sources
May 19, 2026 · $27,680 · Form 4Stock +8.9% versus SPY +1.8%.
May 18, 2026 · $27,680 · Form 4Stock +8.9% versus SPY +1.8%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001382184. Profile company CIK 0001776661. Advantage Solutions Inc.
Recorded role: Chief Executive Officer · ADV.
7 obs. Confidence 58; 5-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 7 of 7 represented trade dates; upper tail 4.931e-3; corrected within the horizon 1.000e+0, across 24734 person/horizon comparisons 6.099e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 6 windows, with 6 wins and upper tail 1.064e-2.
One entry per filing selected from the current 90-day scored feed. Derivatives and known open-market trades below $10,000 are excluded from conviction scoring. These are reported transactions, not live trades. A trade score and an insider's historical Alpha IQ measure different things.